ORIGINAL ARTICLES
Commentary on "Salbutamol exhibits androgenic activity in vitro"
UFR STAPS, France; katia.collomp@univ-orleans.fr
Salbutamol exhibits androgenic activity in vitro
| The first 150 words of the full text of this article appear below. |
Because of the anabolic potency of b2-agonists, the World Antidoping Agency prohibited their systemic use and added them to their doping list. This class of drug is acknowledged to induce significant changes in body composition. Chronic administration of specific beta-2 adrenergic agonists, especially clenbuterol and salmeterol, has been shown to increase skeletal muscle strength and size in several species following relatively short periods of administration. This anabolic effect on skeletal muscle was, however, only found with salbutamol after intravenous administration with implanted minipumps in model animals, possibly because of its short half-life of time of elimination. Regardless, the potential mechanism(s) by which beta-2 agonists mediates anabolic effects remain unclear. The present study therefore investigates potential androgenic activity of salbutamol in vitro and shows anabolic effects of salbutamol through androgen receptor agonistic activity. Further studies will be necessary to determine whether this mechanism could occur in vivo after salbutamol administration at
Relevant Article
- Salbutamol exhibits androgenic activity in vitro
- André O von Bueren, Risheng Ma, Margret Schlumpf, Walter Lichtensteiger
Br. J. Sports Med. 2007 41: 874-878.[Abstract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
